Patent Dimensions in the Development and Production of COVID-19 Vaccines
Abstract The process in which COVID-19 vaccines are developed is sequential and continuously accumulating. On the one hand, comprehensive patent protection is a necessary means to promote research and development. It yields additional returns that pay for the occasionally substantial amounts in R&am...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | deu |
| Published: |
Sciendo
2021-05-01
|
| Series: | Wirtschaftsdienst |
| Online Access: | https://doi.org/10.1007/s10273-021-2923-4 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832570090971725824 |
|---|---|
| author | Tobias Volpert Marcel Riepe |
| author_facet | Tobias Volpert Marcel Riepe |
| author_sort | Tobias Volpert |
| collection | DOAJ |
| description | Abstract The process in which COVID-19 vaccines are developed is sequential and continuously accumulating. On the one hand, comprehensive patent protection is a necessary means to promote research and development. It yields additional returns that pay for the occasionally substantial amounts in R&D expenses. On the other hand, patents can be harmful in a sequential development process as they monopolise knowledge that might become a basis for further research. Economic policy cannot resolve this dilemma, but the various dimensions of a patent system can provide a starting point in mitigating a trade-off. |
| format | Article |
| id | doaj-art-ad84bc85ca3e469391306c95f20bdf19 |
| institution | Kabale University |
| issn | 0043-6275 1613-978X |
| language | deu |
| publishDate | 2021-05-01 |
| publisher | Sciendo |
| record_format | Article |
| series | Wirtschaftsdienst |
| spelling | doaj-art-ad84bc85ca3e469391306c95f20bdf192025-02-02T17:36:57ZdeuSciendoWirtschaftsdienst0043-62751613-978X2021-05-01101538739310.1007/s10273-021-2923-4Patent Dimensions in the Development and Production of COVID-19 VaccinesTobias Volpert0Marcel Riepe1VWL, Hochschule Hamm-LippstadtVWL, Hochschule Hamm-LippstadtAbstract The process in which COVID-19 vaccines are developed is sequential and continuously accumulating. On the one hand, comprehensive patent protection is a necessary means to promote research and development. It yields additional returns that pay for the occasionally substantial amounts in R&D expenses. On the other hand, patents can be harmful in a sequential development process as they monopolise knowledge that might become a basis for further research. Economic policy cannot resolve this dilemma, but the various dimensions of a patent system can provide a starting point in mitigating a trade-off.https://doi.org/10.1007/s10273-021-2923-4 |
| spellingShingle | Tobias Volpert Marcel Riepe Patent Dimensions in the Development and Production of COVID-19 Vaccines Wirtschaftsdienst |
| title | Patent Dimensions in the Development and Production of COVID-19 Vaccines |
| title_full | Patent Dimensions in the Development and Production of COVID-19 Vaccines |
| title_fullStr | Patent Dimensions in the Development and Production of COVID-19 Vaccines |
| title_full_unstemmed | Patent Dimensions in the Development and Production of COVID-19 Vaccines |
| title_short | Patent Dimensions in the Development and Production of COVID-19 Vaccines |
| title_sort | patent dimensions in the development and production of covid 19 vaccines |
| url | https://doi.org/10.1007/s10273-021-2923-4 |
| work_keys_str_mv | AT tobiasvolpert patentdimensionsinthedevelopmentandproductionofcovid19vaccines AT marcelriepe patentdimensionsinthedevelopmentandproductionofcovid19vaccines |